271. Ankylosing spondylitis
531 clinical trials,   343 drugs   (DrugBank: 66 drugs),   41 drug target genes,   141 drug target pathways

Searched query = "Ankylosing spondylitis", "Spondylarthritis ankylopoietica"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.

Search in Page e.g. "Phase 3", "Not recruiting", "Japan"
4 trials found
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT02809781
(ClinicalTrials.gov)
June 201616/6/2016A Pilot Study of MSCs Iufusion and Etanercept to Treat Ankylosing SpondylitisPhase III Study of Human Bone Marrow-Derived Mesenchymal Stem Cells to Treat ASSpondylitis;Spondylitis, Ankylosing;Ankylosis;Arthritis;Spondylarthritis;Spondylarthropathies;Spinal Diseases;Musculoskeletal Diseases;Bone DiseasesBiological: Intravenous infusion of MSCs;Drug: EtanerceptSun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityNanfang Hospital of Southern Medical University;Second Affiliated Hospital of Guangzhou Medical UniversityRecruiting18 Years45 YearsBoth250Phase 2;Phase 3China
2NCT01709656
(ClinicalTrials.gov)
March 201210/10/2012A Molecule Basic Study of Early Warning for New Pathogenic Risk of Ankylosing SpondylitisA Molecule Basic Study of Early Warning for New Pathogenic Risk of Ankylosing SpondylitisAnkylosing SpondylitisBiological: MSC;Drug: celecoxib, Celebrex®Sun Yat-sen UniversityNULLCompleted16 Years65 YearsBoth120N/AChina
3ChiCTR-TRC-11001417
2011-06-012011-07-10clinical study of Mecenchymal Stem Cells transplantation in Ankylosing Spondylitisclinical study of Mecenchymal Stem Cells transplantation in Ankylosing Spondylitis Ankylosing Spondylitis (AS)1:oral salicylazosulfapyridine and indomethacin;2:Mecenchymal Stem Cells(MSC) transplantation ;Sun Yat-sen Memorial Hospital of Sun Yat-sen UniversityNULLRecruitingBoth1:80;2:80;I+2 (Phase 1;Phase 2)China
4NCT01420432
(ClinicalTrials.gov)
January 201111/8/2011Safety and Efficacy Study of Umbilical Cord/Placenta-Derived Mesenchymal Stem Cells to Treat Ankylosing Spondylitis (AS)Phase II Study of Umbilical Cord/Placenta-Derived Mesenchymal Stem Cells to Treat ASAnkylosing SpondylitisBiological: Human umbilical cord-derived MSCsShandong UniversityNULLRecruiting18 Years60 YearsBoth10Phase 1China